NCT07301138 2025-12-24BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia PatientsRuijin HospitalPhase 2 Not yet recruiting23 enrolled